Kefir: the next superfood for diabetes?

NCT ID NCT06695221

Recruiting now Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether drinking traditional kefir every day for 12 weeks can improve blood sugar control and heart health in 156 adults who are overweight and either at risk for or already have type 2 diabetes. Participants will drink either kefir or plain milk. The main goal is to see if kefir lowers average blood sugar levels (HbA1c).

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: traditional kefir (fermented milk drink)
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage blood sugar and reduce heart disease risk in people with or at risk for type 2 diabetes.
What could go wrong: This is a small, early-stage study (156 people) testing a dietary supplement, not a drug. Results may not be dramatic or apply to everyone, and kefir may cause digestive discomfort in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES DIABETES MELLITUS, TYPE 2 SYSTEMIC INFLAMMATORY RESPONSE

Kefir: the next superfood for diabetes?

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions